Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment

By Galmarini Carlos M.   D’Incalci Maurizio   Allavena Paola  

Marine Drugs, Vol. 12, Iss. 2, 2014-01 ,pp. : 719-733

MDPI

Access to resources Recommend Favorite

c-Jun N-Terminal Kinase Phosphorylation Is a Biomarker of Plitidepsin Activity

By Muñoz-Alonso María J.   Álvarez Enrique   Guillén-Navarro María José   Pollán Marina   Avilés Pablo   Galmarini Carlos M.   Muñoz Alberto  

Marine Drugs, Vol. 11, Iss. 5, 2013-05 ,pp. : 1677-1692

MDPI

Access to resources Recommend Favorite

A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on Survival

By Pecqueux Mathieu   Liebetrau Isabell   Werft Wiebke   Dienemann Hendrik   Muley Thomas   Pfannschmidt Joachim   Müssle Benjamin   Rahbari Nuh   Schölch Sebastian   Büchler Markus W.   Weitz Jürgen   Reissfelder Christoph   Kahlert Christoph  

International Journal of Molecular Sciences, Vol. 17, Iss. 10, 2016-10 ,pp. : 1755-1755

MDPI

Access to resources Recommend Favorite

Phase II Study of Biweekly Plitidepsin as Second-Line Therapy for Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

By Dumez Herlinde   Gallardo Enrique   Culine Stephane   Galceran Joan Carles   Schöffski Patrick   Droz Jean P.   Extremera Sonia   Szyldergemajn Sergio   Fléchon Aude  

Marine Drugs, Vol. 7, Iss. 3, 2009-09 ,pp. : 451-463

MDPI

Access to resources Recommend Favorite

Phase II Randomized Study of Plitidepsin (Aplidin), Alone or in Association with L-carnitine, in Patients with Unresectable Advanced Renal Cell Carcinoma

By Schöffski Patrick   Guillem Vincente   Garcia Margarita   Rivera Fernando   Tabernero Josep   Cullell Martin   Lopez-Martin Jose Antonio   Pollard Patricia   Dumez Herlinde   Muro Xavier Garcia del   Paz-Ares Luis  

Marine Drugs, Vol. 7, Iss. 1, 2009-03 ,pp. : 57-70

MDPI

Access to resources Recommend Favorite